Kampala, Uganda | THE INDEPENDENT | The Uganda Virus Research Institute-UVRI is set to conduct phase one trials of the Rift Valley Fever human vaccine. The trials are expected to start next month. The trial will use an improved version of ChAdOx1-GnGc-a vaccine currently only used by animals to treat RVF …
Read More »